Coya Therapeutics, Inc. (COYA) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts COYA Hot Sheet
Join SI Premium – FREE
Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q1 EPS of ($0.44), $0.02 better than the analyst estimate of ($0.46).
For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- RBC Capital Downgrades EyePoint Inc. (EYPT) to Sector Perform
- Goldman Sachs Starts Scribe Therapeutics Inc (SCTX) at Early-Stage Biotech
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
